Effect of SARS-CoV-2 B.1.1.7 mutations on spike protein structure and function | Nature Structural & Molecular Biology
From Alpha to Epsilon: Consortium study illuminates surfaces of Spike most resistant to antibody escape
ADAM10 and ADAM17 promote SARS‐CoV‐2 cell entry and spike protein‐mediated lung cell fusion | EMBO reports
Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike - ScienceDirect
Spike-Protein vom SARS-CoV-2 ist flexibler als gedacht | Max-Planck-Gesellschaft
Pressemitteilungen - Messen, was verbindet – Gewebeschäden durch Zellfusion in COVID-19 und die Rolle des Spikeproteins - Paul-Ehrlich-Institut
Frontiers | The ORF8 Protein of SARS-CoV-2 Modulates the Spike Protein and Its Implications in Viral Transmission
Discovering potential emerging SARS-CoV-2 variants
Cell surface detection of vimentin, ACE2 and SARS-CoV-2 Spike proteins reveals selective colocalization at primary cilia | Scientific Reports
Sars-Coronavirus-2: Spikeprotein ist Gift fürs Herz | MDR.DE
Research finds Covid-19 spike protein binds to cells in the heart and could help to explain some effects of severe infection - BHF
Bad News Wrapped in Protein: Inside the Coronavirus Genome - The New York Times
Spike-Protein vom SARS-CoV-2 ist flexibler als gedacht | Max-Planck-Gesellschaft
ox az vaccine spike protein compares to coronavirus | University of Southampton
Thiopurines inhibit coronavirus Spike protein processing and incorporation into progeny virions | PLOS Pathogens
Pressemitteilungen - Antikörper COVID-19-Geimpfter erkennen andere Strukturen des Spike-Proteins als Antikörper SARS-CoV-2-Infizierter - Paul-Ehrlich-Institut
Mutation Allows Coronavirus to Infect More Cells, Study Finds. Scientists Urge Caution. - The New York Times
Chemist Developing 3D Simulations of Coronavirus Spike Proteins | University of Arkansas
Free fatty acid binding pocket in the locked structure of SARS-CoV-2 spike protein | Science
Nein, diese Studie belegt nicht die Gefahr von Spike-Proteinen in Corona-Impfstoffen | Faktencheck
A Better COVID-19 Vaccine Could Be Less Spike-Centric - The Atlantic
Rapid Development of SARS-CoV-2 Spike Protein Receptor-Binding Domain Self-Assembled Nanoparticle Vaccine Candidates | ACS Nano
